6[11]Powell MF, Grey H, Gaeta F, et al. improved induction of melanima reactive CTL with peptide reactive in different biologic media[J] .J Pharm Sci, 1992,81(8):731 - 735.
7[12]Van Regenmortel MH, Muller S. D-peptides as immunogens and diagnostic reagents [J]. Curr Opin Biotechnol, 1998,9(4) :377 - 382.
8[13]Brinckerhoff LH, Kalashnikov VV, Thompson LW, et al.Terminal modifictioninhibit proteolytic degradation of an immunogenic MART-1 (27-35) peptide :implication for peptide vaccines[J]. Int J Cancer, 1999,83(3) :326 - 334.
9[14]Ayyoub M, Mazarguil H, Monsarrat B, et al. A structurebased approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells[J] .J Biol Chem, 1999,274(15) :10 227 - 10 234.
10[16]Reynolds SR, Oratz R, Shapiro RL, et al. Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine[J]. Int J Cancer, 1997,72(6) :972 - 976.
